incorporation of fluorine (usually CF3 group or fluorine
atom(s)) is a powerful tool ofmoderndrug designand drug
discovery.3
Starting bromo enones 1aꢀe were prepared in high yields
from R,β-unsaturated CF3ketones by the classical brominationꢀ
dehydrobromination sequence without isolation of the inter-
mediate dibromo derivatives (Scheme 1).6
Scheme 1. Synthesis of Starting Bromo Enones 1aꢀe
First, the model reaction of enone 1a with N,N0-
dimethylethylenediamine (DMEDA) was investigated. We
envisioned that this reaction proceeds as a cascade Michael
additionꢀnucleophilic substitution process to give trifluoro-
acetylated piperazine 2. However, the reaction of enone 1a
with DMEDA surprisingly afforded compound 3a, having
a skeleton of 3-(trifluoromethyl)piperazin-2-one.
Figure 1. Some piperazine-derived drugs.
R,β-Unsaturated carbonyl compounds (enones, enals,
esters) are classical scaffolds for reactions with nucleo-
philes and binucleophiles. They have been studied inten-
sively for the synthesis of various carbo- and heterocyclic
systems.4 CF3 enones are of special interest because they are
very valuable building blocks for the preparation of various
trifluoromethylated heterocycles.5 The reactivity of CF3
enones often differs significantly from nonfluorinated ana-
logues in exhibiting the unique role of fluorine. For example,
we have found unusual reaction of R-bromoalkenyl trifluo-
romethyl ketones with secondary amines leading easily to
captodative carbonyl-bearing aminoalkenes which are read-
ily transformed into indenol derivatives6 in contrast to their
nonfluorinated analogues.7 On the other hand, the capto-
dative formyl(amino)alkenes undergo surprising transfo-
rmations upon treatment with mono- and binucleophiles.8
Considering the significance of both the trifluoromethyl
group and piperazine moiety, we decided to investigate the
reaction of trifluoromethyl R-bromo enones with symme-
trically substituted ethylenediamines as a short pathway to
trifluoroacetylated piperazines.
Table 1. Reaction of Enone 1a with DMEDA
entry
solvent
Et2O
base
yielda (%)
1
DMEDA
Et3N
Et3N
Et3N
Et3N
Et3N
Et3N
Et3N
Et3N
Et3N
Et3N
Et3N
Et3N
Et3N
Et3N
Et3N
42
51
25
19
84
8
2
Et2O
3
EtOH
4
(CF3)2CH(OH)
CF3CH2OH
Pyridine
DMSO
DMF
5
6
(3) Selected publications: (a) Filler, R.; Kobayashi, Y.; Yagulpolskii,
L. M. Organofluorine Compounds in Medicinal Chemistry andBiomedical
Applications; Elsevier: Amsterdam, 1993. (b) Fluorine-Containing Amino
Acids. Synthesis and Properties; Kukhar, V. P., Soloshonok, V. A., Eds.;
John Wiley & Sons: Chichester, 1995. (c) Hiyama, V. A. Organofluorine
Compounds: Chemistry and Properties; Springer-Verlag: Berlin, 2000;
Chapter 5, pp 137ꢀ182. (d) Smart, B. E. J. Fluorine Chem. 2001, 109, 3.
(4) For reviews, see: (a) Rulev, A. Yu Russ. Chem. Rev. 1998, 67, 279.
7
18
18
30
20
36
59
50
6
8
9
acetone
CH2Cl2
THF (ꢀ20 °C)
THF
10
11
12
13
14
15
16
ꢀ
MeCN
(b) De Kimpe, N.; Verhe, R. The Chemistry of R-Haloketones,
R-Haloaldehydes and R-Haloimines; Patai, S., Rappoport, Z., Eds.; Wiley:
New York, 1988. For examples, see: (c) Rulev, A. Yu.; Maddaluno, J. J. Phys.
Org. Chem. 2002, 15, 590. (d) Rulev, A. Yu.; Azad, S.; Kotsuki, H.;
Maddaluno, J. Eur. J. Org. Chem. 2010, 6423.
Et3N
PhH
24
0
H2O
(5) (a) Nenajdenko, V. G.; Sanin, A. V.; Balenkova, E. S Molecules
1997, 2, 186. (b) Nenaidenko, V. G.; Sanin, A. V.; Balenkova, E. S. Russ.
Chem. Rev. 1999, 68, 437. (c) Druzhinin, S. V.; Balenkova, E. S.;
Nenajdenko, V. G. Tetrahedron 2007, 63, 7753. (d) Nenajdenko,
V. G.; Balenkova, E. S. ARKIVOC 2011, 246.
(6) Rulev, A. Yu.; Ushakov, I. A.; Nenajdenko, V. G.; Balenkova,
E. S.; Voronkov, M. G. Eur. J. Org. Chem. 2007, 6039. Rulev, A. Yu.;
Ushakov, I. A.; Nenajdenko, V. G. Tetrahedron 2008, 64, 8073.
(7) Rulev, A. Yu. Russ. Chem. Rev. 2002, 71, 195.
(8) (a) Rulev, A. Yu.; Larina, L. I.; Keiko, N. A.; Voronkov, M. G.
J. Chem. Soc., Perkin Trans. 1 1999, 1567. (b) Rulev, A. Yu.; Larina,
L. I.; Voronkov, M. G. Tetrahedron Lett. 2000, 41, 10211. (c) Rulev, A.
Yu.; Larina, L. I.; Voronkov, M. G. Russ. J. Gen. Chem. 2001, 71, 1891.
(d) Rulev, A. Yu.; Larina, L. I.; Voronkov, M. G. Molecules 2001, 6, 892.
(e) Rulev, A. Yu.; Novokshonov, V. V.; Chuvashev, Yu. A.; Fedorov,
S. V.; Larina, L. I. Mendeleev Commun. 2003, 23.
a 19F NMR yields (rt, 48 h).
Deep structural changes are observed for the product 3a
having the trifluoromethyl group migrated in the adjacent
position. This type of compounds is a rare type of hetero-
cycles which is difficult to prepare. To the best of our
knowledge only two approaches to CF3 substituted piper-
azines (based on the trifluoropyruvic acid derivatives9 or
(9) Saloutin, V. I.; Piterskikh, I. A.; Pashkevich, K. I.; Kodess, M. I.
Bull. Acad. Sci. USSR 1983, 32, 2312.
B
Org. Lett., Vol. XX, No. XX, XXXX